Asmaa Abdelmaksoud | Molecular Pathology | Best Scholar Award

Published on by Cognitive Scientist Awards

Dr. Asmaa Abdelmaksoud | Molecular Pathology | Best Scholar Award

Ohio State University | United States

Dr. Asmaa Abdelmaksoud, Ph.D., is a distinguished molecular biologist and pathology researcher currently serving as a Research Associate in the Department of Ophthalmology at The Ohio State University Wexner Medical Center and a Senior Fellow in the Department of Pathology at the National Liver Institute, Menoufia University, Egypt. She holds advanced degrees in molecular biology, analytical biochemistry, and histology from Menoufia and Sadat City Universities, where she also developed expertise in molecular pathology and genetic engineering. Her professional journey reflects a strong blend of academic leadership and scientific innovation, having managed the Sustainable Science Institute Collaborative Research Centre Biobank in Egypt while mentoring graduate students and leading workshops in molecular biology and pathology. Dr. Abdelmaksoud’s research interests focus on cancer biology, hepatocellular carcinoma, genetic alterations, and molecular mechanisms underlying disease progression, supported by international training experiences in Spain, France, and the United States. Her research skills encompass histopathology, molecular diagnostics, and advanced laboratory methodologies. She has earned notable recognitions, including Best Abstract Awards from prestigious international pathology congresses for her groundbreaking work on hepatocellular carcinoma. Committed to advancing molecular diagnostics and translational medicine, Dr. Abdelmaksoud continues to contribute to global biomedical research with excellence, mentorship, and scientific integrity.

Profile: ORCID

Featured Publications

Elzbieta Zlowocka-Perlowska | Micronutrients and Kidney Cancer | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Elzbieta Zlowocka-Perlowska | Micronutrients and Kidney Cancer | Best Researcher Award

Pomeranian Medical University | Poland

Dr. Elżbieta Złowocka-Perłowska is an accomplished Polish medical scientist specializing in molecular oncology and hereditary cancer research. She earned her master’s degree in biology from the University of Szczecin and a doctorate in medical sciences with highest distinction from the Pomeranian Medical University in Szczecin, where she currently serves at the Center for Hereditary Tumors and the Department of Genetics and Pathomorphology. Her professional expertise lies in molecular diagnostics, cancer biomarkers, and the prognostic role of trace and microelements in bladder and kidney cancers. She leads innovative research investigating correlations between blood and serum element levels and patient survival, aiming to integrate these biomarkers into predictive cancer models for personalized therapy development. Dr. Złowocka-Perłowska possesses strong research skills in molecular genetics, laboratory diagnostics, epidemiological modeling, and translational oncology. Her distinguished career includes numerous national and international awards, such as recognition from the World Scientist Forum and multiple Rector’s Awards, along with significant contributions to over fifty scientific publications and several patents. She has also collaborated internationally and mentored emerging researchers. Through her pioneering work, Dr. Złowocka-Perłowska continues to advance the understanding of hereditary and molecular mechanisms in cancer, contributing to future innovations in clinical diagnostics and targeted therapies.

Profile: ORCID

Featured Publications

PhongSon Dinh | Gene function analysis | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. PhongSon Dinh | Gene function analysis | Best Researcher Award

Dr. Dinh Phong Son is a prominent researcher at Duy Tan University, Vietnam, specializing in laboratory medicine and molecular medicine. With a PhD from Guangxi Medical University, China, he is dedicated to advancing the field of molecular biology and medical diagnostics. His work focuses on identifying biomarkers for early disease detection and investigating gene targets for targeted therapies. He actively contributes to scientific advancements in understanding complex diseases such as cancer, diabetes, and cardiovascular diseases. Through his expertise in molecular techniques like CRISPR/Cas9, PCR, and sequencing, Dr. Son plays a vital role in improving medical diagnostics and treatments. 🧬🔬

Profile

Education 🎓

Dr. Dinh Phong Son holds a Doctorate (Ph.D.) in Molecular Medicine from Guangxi Medical University, China, after earning his degree in Laboratory Medicine from Hue University of Medicine and Pharmacy, Vietnam. His educational background has equipped him with the expertise in molecular biology, enabling him to explore complex diseases at a molecular level and work on cutting-edge technologies in the field of gene editing and disease diagnosis. 🎓📚

Experience 👨‍🏫

Dr. Dinh Phong Son has significant experience in molecular medicine, focusing on the development of biomarkers for early disease diagnosis and treatment. With expertise in molecular biology techniques such as PCR, qPCR, CRISPR/Cas9, and sequencing, he has conducted extensive research on diseases like cancer, cardiovascular disorders, and diabetes. His work integrates bioinformatics and molecular assays to understand gene functions and identify potential drug targets. He is actively contributing to scientific publications and advancing the research community’s knowledge in disease diagnostics and therapies. 🔬💡

Research Interests 🔬

Dr. Dinh Phong Son’s research focuses on molecular techniques for disease detection and gene therapy. His current work includes exploring circRNA, miRNA, mRNA, and their role in diseases like coronary heart disease and cancer. Dr. Son is particularly interested in developing diagnostic biomarkers and therapeutic targets for systemic diseases using next-generation sequencing and CRISPR/Cas9. He also investigates the interaction networks between lncRNA, circRNA, miRNA, genes, and proteins, aiming to create molecular-based solutions for precision medicine. His research paves the way for future advancements in molecular diagnostics and personalized therapies. 🔬🧬

Awards & Recognitions 🏅

Dr. Dinh Phong Son’s contributions to molecular medicine have earned him recognition in the scientific community. His research publications, particularly on gene networks and biomarkers in cardiovascular and cancer research, have garnered widespread attention. He is currently a nominee for the Best Researcher Award, reflecting his ongoing commitment to advancing the fields of molecular biology, gene therapy, and disease diagnostics. His work is an important step toward improving public health outcomes through the application of molecular techniques. 🏆🏅

Publications 📚

  • Identification and assessment of hub genes and miRNAs coregulatory associated with immune infiltrations and drug interactions in latent tuberculosis based on MicroarrayData analysis, molecular docking, and dynamic simulation

    Biochemistry and Biophysics Reports
    2025-03 | Journal article
    DOI: 10.1016/j.bbrep.2025.101952
    CONTRIBUTORS: PhongSon Dinh; ChauMyThanh Tran; ThiPhuongHoai Dinh; Hai-Anh Ha; Aigul Utegenova; Awais Ali; Abdulaziz Alamri

  • Hsa_circRNA_0000284 acts as a ceRNA to participate in coronary heart disease progression by sponging miRNA-338-3p via regulating the expression of ETS1

    Journal of Biomolecular Structure and Dynamics
    2024-07-02 | Journal article
    DOI: 10.1080/07391102.2023.2225109
    CONTRIBUTORS: PhongSon Dinh; ChauMyThanh Tran; ThiPhuongHoai Dinh; Awais Ali; ShangLing Pan

  • Potential diagnostic value of serum microRNAs for 19 cancer types: a meta-analysis of bioinformatics data

    Journal of Biomolecular Structure and Dynamics
    2024-03-15 | Journal article
    DOI: 10.1080/07391102.2024.2328744
    CONTRIBUTORS: ChauMyThanh Tran; PhongSon Dinh

  • Identification of hsa_circ_0001445 of a novel circRNA-miRNA-mRNA regulatory network as potential biomarker for coronary heart disease

    Frontiers in Cardiovascular Medicine
    2023-03-14 | Journal article
    DOI: 10.3389/fcvm.2023.1104223
    Part of ISSN: 2297-055X
    CONTRIBUTORS: PhongSon Dinh; JunHua Peng; ThanhLoan Tran; DongFeng Wu; ChauMyThanh Tran; ThiPhuongHoai Dinh; ShangLing Pan